Chenlu Wu1, Jiafei Ying2, Mei Dai2, Jing Peng2, Danhua Zhang3. 1. Department of Cardiology, The Second Xiangya Hospital, Central South University, Changsha, 410011, Hunan, People's Republic of China. 2. Department of General Surgery, The Second Xiangya Hospital, Central South University, No. 139, Mid Renmin Road, Furong, Changsha, 410011, Hunan, People's Republic of China. 3. Department of General Surgery, The Second Xiangya Hospital, Central South University, No. 139, Mid Renmin Road, Furong, Changsha, 410011, Hunan, People's Republic of China. zhangdanhua@csu.edu.cn.
Abstract
PURPOSE: To investigate the roles of DDR2 and IFITM1 in breast cancer (BC). METHODS: The expression of DDR2 and IFITM1 in BC tissues and cell lines was measured. DDR2 and/or IFITM1 were knocked down in BT20 and MDA-MB-231 cells, after which the viability, mobility and apoptosis of the cells were tested. Xenograft mouse models were established through subcutaneous tumor transplantation. RESULTS: DDR2 and IFITM1 were highly expressed in invasive BC tissues and cell lines. Overexpression of DDR2 and/or IFITM1 was associated with poorer clinical outcomes and patient survival. Knockdown of DDR2 or IFITM1 suppressed the viability and invasiveness of BT20 and MDA-MB-231 cells and restrained the growth of xenograft tumors in nude mice. Simultaneous knockdown of IFITM1 and DDR2 surpassed knockdown of IFITM1 alone in suppressing BC development. CONCLUSIONS: DDR2 and IFITM1 are co-expressed to facilitate the malignant behaviors of BC cells and promote the development of tumors.
PURPOSE: To investigate the roles of DDR2 and IFITM1 in breast cancer (BC). METHODS: The expression of DDR2 and IFITM1 in BC tissues and cell lines was measured. DDR2 and/or IFITM1 were knocked down in BT20 and MDA-MB-231 cells, after which the viability, mobility and apoptosis of the cells were tested. Xenograft mouse models were established through subcutaneous tumor transplantation. RESULTS: DDR2 and IFITM1 were highly expressed in invasive BC tissues and cell lines. Overexpression of DDR2 and/or IFITM1 was associated with poorer clinical outcomes and patient survival. Knockdown of DDR2 or IFITM1 suppressed the viability and invasiveness of BT20 and MDA-MB-231 cells and restrained the growth of xenograft tumors in nude mice. Simultaneous knockdown of IFITM1 and DDR2 surpassed knockdown of IFITM1 alone in suppressing BC development. CONCLUSIONS: DDR2 and IFITM1 are co-expressed to facilitate the malignant behaviors of BC cells and promote the development of tumors.
Authors: Yi Fan; Zhe Xu; Jin Fan; Liu Huang; Ming Ye; Kun Shi; Zheng Huang; Yaqiong Liu; Langchi He; Jiezhen Huang; Yibin Wang; Qiufeng Li Journal: Am J Transl Res Date: 2016-06-15 Impact factor: 4.060
Authors: Taylor E Escher; Asona J Lui; Eric S Geanes; Katherine R Walter; Ossama Tawfik; Christy R Hagan; Joan Lewis-Wambi Journal: Mol Cancer Res Date: 2019-01-17 Impact factor: 5.852
Authors: David Borg; Charlotta Hedner; Alexander Gaber; Björn Nodin; Richard Fristedt; Karin Jirström; Jakob Eberhard; Anders Johnsson Journal: Biomark Res Date: 2016-05-14